EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

On‐Demand Controlled Release Multi‐Drugs Delivery System for Spatiotemporally Synergizing Antitumor Immunotherapy

Chenglin Liang, Hanxiao Yang, Tongtong Li, Xiaojuan Jiang, Xinni Li, Chen Gao, Lin Hou iD

Advanced Science · 2025

DOI: 10.1002/advs.202414233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Chenglin Liang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, 450001, …. Hauptthemen laut MEDLINE: Immunotherapy, Drug Delivery Systems, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joint Funds of Henan Province Foundation for Science and Technology, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although cytotoxic T lymphocytes (CTLs) activation combined with programmed cell death‐1 (PD‐1)/programmed cell death ligand‐1 (PD‐L1) axis blockade have emerged as an effective strategy to improve immunotherapeutic potency, it remains challenging to realize the spatiotemporal synergy of these two components. Herein, the study reports an engineered bacterial‐based delivery system that can simultaneously promote CTLs infiltration and control PD‐L1 binding protein (PD‐L1 trap) release on demand at tumor site. The drug release button of this tumor targeting system is the specific temperature, which is accomplished by dual‐modified melanin nanoparticles with photothermal conversion capacity on the engineered bacterial. These dual‐modified nanoparticles can form in situ reservoir of heat supplier and antitumor immunity activator once arriving at tumor microenvironment (TME). Importantly, the study establishes the personalized administration regimen according to TME changes, and perform local laser irradiation to trigger PD‐L1 trap production only in TME when infiltrated CTLs reach the highest level. This work provides a flexible platform for optimizing cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyDrug Delivery SystemsNeoplasmsAnimalsMiceT-Lymphocytes, CytotoxicTumor MicroenvironmentB7-H1 AntigenHumansNanoparticlesDelayed-Action PreparationsCell Line, Tumor

Stichwörter der Autor:innen

CTLs activationPD‐L1 trap release as neededmuti‐drugs deliveryspatiotemporally synergizing

Substanzen

B7-H1 AntigenDelayed-Action Preparations

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, 450001, China.

ORCID-Profile: Lin Hou

Förderung

  • Joint Funds of Henan Province Foundation for Science and Technology
  • National Natural Science Foundation of China

Zitieren

APA

Liang, C., Yang, H., Li, T., Jiang, X., Li, X., Gao, C., & Hou, L. (2025). On‐Demand Controlled Release Multi‐Drugs Delivery System for Spatiotemporally Synergizing Antitumor Immunotherapy. Advanced Science. https://doi.org/10.1002/advs.202414233

Vancouver

Liang C, Yang H, Li T, Jiang X, Li X, Gao C, et al. On‐Demand Controlled Release Multi‐Drugs Delivery System for Spatiotemporally Synergizing Antitumor Immunotherapy. Advanced Science. 2025. doi:10.1002/advs.202414233

BibTeX
@article{Liang2025,
  author = {Liang, Chenglin and Yang, Hanxiao and Li, Tongtong and Jiang, Xiaojuan and Li, Xinni and Gao, Chen and Hou, Lin},
  title = {On‐Demand Controlled Release Multi‐Drugs Delivery System for Spatiotemporally Synergizing Antitumor Immunotherapy},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202414233}
}
Kostenlos starten →